TCL Archive Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial July 25, 2014
TCL Archive Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal December 16, 2011
TCL Archive In Brief: ACS Estimates 502,000 U.S. Cancer Deaths, 178,000 Avoidable With Early Diagnosis March 17, 1989
